MedPath

relationship between vitamin D treatment with liver involvement severity

Phase 2
Conditions
non alcoholic fatty liver disease.
Fatty (change of) liver, not elsewhere classified
K76.0
Registration Number
IRCT20150802023468N6
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
100
Inclusion Criteria

vitamin D deficiency
patients suffered from non- alcoholic fatty liver disease

Exclusion Criteria

alcohol consumption history
positive HBS Ag
auto immunize hepatitis
cancers
melitus diabetics
thyroid disease
chronic kidney disease

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Grade ultrasound. Timepoint: At the beginning of the study, 4 months. Method of measurement: Sonography.;Vitamin D. Timepoint: At the beginning of the study, 4 months. Method of measurement: blood test.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath